Literature DB >> 16919343

Primary hyperparathyroidism and the cardiovascular system.

Thomas J Kiernan, Anne Marie O'Flynn, John H McDermott, Peter Kearney.   

Abstract

The role of primary hyperparathyroidism (PHPT) in heart disease is still somewhat uncertain in many respects. Patients with PHPT seem to have an increase in mortality and this seems mainly due to an overrepresentation of cardiovascular death. PHPT is reported to be associated with hypertension, disturbances in the renin-angiotensin-aldosterone system, cardiac arrhythmias as well as structural and functional alterations in the vascular wall. There is an increased prevalence of cardiac structural abnormalities such as LVH and functional properties of the heart may be affected by the hyperparathyroid condition as well. We report the case of a 65-year-old woman with no cardiac risk factors apart from her age and type 2 diabetes who presented in cardiogenic shock. Extensive evaluation for the aetiology of the cardiomyopathy revealed solely a diagnosis of primary hyperparathyroidism. Cardiac manifestations of primary hyperparathyroidism have been reported before but to our knowledge this is the first description of severe left ventricular function secondary to PHPT. We believe that this atypical presentation of primary hyperparathyroidism causing left ventricular cardiomyopathy warrants further attention, and that a diagnosis of primary hyperparathyroidism should always be considered in patients with systolic as well as diastolic left ventricular dysfunction, and no other obvious cause.

Entities:  

Mesh:

Year:  2006        PMID: 16919343     DOI: 10.1016/j.ijcard.2006.05.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

Review 2.  The Parathyroid Gland and Heart Disease.

Authors:  Spandana J Brown; Mary D Ruppe; Laila S Tabatabai
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

3.  Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness.

Authors:  Jason Andrade; Lee Er; Andrew Ignaszewski; Adeera Levin
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

Review 4.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03

5.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

6.  The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss.

Authors:  Göknur Yorulmaz; Aysen Akalın; Olga Meltem Akay; Garip Şahin; Cengiz Bal
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency.

Authors:  Laura P B Elbers; Marije Wijnberge; Joost C M Meijers; Dennis C W Poland; Dees P M Brandjes; Eric Fliers; Victor E A Gerdes
Journal:  Endocr Connect       Date:  2018-01-09       Impact factor: 3.335

8.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

Review 9.  The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.

Authors:  Ming-Hui Zheng; Fu-Xing-Zi Li; Feng Xu; Xiao Lin; Yi Wang; Qiu-Shuang Xu; Bei Guo; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-20       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.